Tone mix
Week by week 52 weeks
Share of Capricor Therapeutics Inc's 688 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jan 12, 2026 · tone -100Capricor Therapeutics (NASDAQ:CAPR) Downgraded to Sell Rating by Wall Street Zen-133
- Week of Oct 5, 2026 · tone +99Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress+117
- Week of Oct 20, 2025 · tone +100Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Potential 234% Upside With Promising Clinical Pipeline+101
- Week of Dec 22, 2025 · tone -50Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory-86
- Week of Sep 22, 2025 · tone +60Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting+72
- Week of Jul 7, 2025 · tone -50Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy-57
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Capricor Therapeutics Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | 0 |
| Last 30 sessions | 68 | -18 |
| Last 90 sessions | 395 | -18 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletProQR Therapeutics (NASDAQ:PRQR) & Capricor Therapeutics (NASDAQ:CAPR) Head-To-Head ContrastNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| ProQR Therapeutics (NASDAQ:PRQR) & Capricor Therapeutics (NASDAQ:CAPR) Head-To-Head Contrast | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCapricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society CongressPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 2, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHead-To-Head Survey: Coherus Oncology (NASDAQ:CHRS) vs. Capricor Therapeutics (NASDAQ:CAPR)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Survey: Coherus Oncology (NASDAQ:CHRS) vs. Capricor Therapeutics (NASDAQ:CAPR) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 1, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletCapricor Therapeutics - CAPR - Stock Price & NewsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Capricor Therapeutics - CAPR - Stock Price & News | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, September 30, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- seekingalpha.com · 1 outletCapricor jumps as study shows longer-term effects of deramiocel (CAPR:NASDAQ)Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Capricor jumps as study shows longer-term effects of deramiocel (CAPR:NASDAQ) | seekingalpha.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Capricor Therapeutics Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.